<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2015-08-18 03:24:32Foreign relations Law Government Patent law Compulsory license Imatinib Novartis Doha Declaration TRIPS Agreement Pharmaceutical industry Pharmaceutical drug Knowledge Ecology International |
Add to Reading List |
Microsoft Word - 150818_Open Letter CL Glivec Colombia_BD Format | Microsoft Word - Doha Declaration _Arabic_.docDocID: 1tRXy - View Document |
 | Regulation Impact StatementDocID: 1r9iA - View Document |
| Microsoft Word - 150818_Open Letter CL Glivec Colombia_BD FormatDocID: 1qTMS - View Document |
 | Microsoft Word - Report_Questionnaire Q94_2004_APPENDIX A.docDocID: 1qI4h - View Document |
 | Microsoft Word - Report_Questionnaire Q94_2004_FINAL.docDocID: 1pnfG - View Document |